Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Lüftner

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Journal of Cancer Research and Clinical Oncology|April 13, 2022
Systemic therapy of metastatic breast cancer: a plea for confirmation of subtypes by genomic assaysDiana Lüftner
Breast Care (Basel, Switzerland)|April 26, 2019
Approval by Authorities Does Not Allow For Suboptimal Study Conduct but Offers New Academic PossibilitiesDiana Lüftner
Wiener Klinische Wochenschrift|March 20, 2004
Breast cancer patients should not live without a HER-2/neu tissue result--but how safe can they live with it?Diana Lüftner
The Breast Journal|May 12, 2015
Clinical Practice Guidelines for Breast Cancer: Current LimitationsDiana Lüftner
Current Opinion in Obstetrics & Gynecology|November 7, 2022
New treatment options for hormone receptor positive breast cancer in 2023Diana Lüftner
Onkologie|October 27, 2005
Pegfilgrastim -- rational drug design for the management of chemotherapy-induced neutropeniaDiana Lüftner, Kurt Possinger
Breast Care (Basel, Switzerland)|April 26, 2019
What Does the Pipeline Promise about Upcoming Biosimilar Antibodies in Oncology?Antonia Busse, Diana Lüftner
Pflege Zeitschrift|December 19, 2003
[Anemia and neutropenia in oncologic patients: modern growth factors simplify therapy]Diana Lüftner, Diane Jozereau
Expert Review of Molecular Diagnostics|April 20, 2002
Nuclear matrix proteins as biomarkers for breast cancerDiana Lüftner, Kurt Possinger
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 27, 2016
Breast cancer and bone metastases: a call for appropriate treatmentDiana Lüftner, Daniela Niepel
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Journal of Cancer Research and Clinical Oncology|April 13, 2022
Systemic therapy of metastatic breast cancer: a plea for confirmation of subtypes by genomic assaysDiana Lüftner
Breast Care (Basel, Switzerland)|April 26, 2019
Approval by Authorities Does Not Allow For Suboptimal Study Conduct but Offers New Academic PossibilitiesDiana Lüftner
Wiener Klinische Wochenschrift|March 20, 2004
Breast cancer patients should not live without a HER-2/neu tissue result--but how safe can they live with it?Diana Lüftner
The Breast Journal|May 12, 2015
Clinical Practice Guidelines for Breast Cancer: Current LimitationsDiana Lüftner
Current Opinion in Obstetrics & Gynecology|November 7, 2022
New treatment options for hormone receptor positive breast cancer in 2023Diana Lüftner
Onkologie|October 27, 2005
Pegfilgrastim -- rational drug design for the management of chemotherapy-induced neutropeniaDiana Lüftner, Kurt Possinger
Breast Care (Basel, Switzerland)|April 26, 2019
What Does the Pipeline Promise about Upcoming Biosimilar Antibodies in Oncology?Antonia Busse, Diana Lüftner
Pflege Zeitschrift|December 19, 2003
[Anemia and neutropenia in oncologic patients: modern growth factors simplify therapy]Diana Lüftner, Diane Jozereau
Expert Review of Molecular Diagnostics|April 20, 2002
Nuclear matrix proteins as biomarkers for breast cancerDiana Lüftner, Kurt Possinger
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 27, 2016
Breast cancer and bone metastases: a call for appropriate treatmentDiana Lüftner, Daniela Niepel
Pageof 18